Mountain View, CACIK 20920211 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
85 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Cg Oncology Inc | 1.52M | $62.91M | 47.8% | +1.52M | New Position |
| 2 | Soleno Therapeutics Inc | 130.1K | $6.02M | 4.6% | +130.1K | New Position |
| 3 | Revolution Medicines Inc | 65.8K | $5.24M | 4.0% | +65.8K | New Position |
| 4 |
| Liquidia Corporation |
| 91.3K |
| $3.15M |
| 2.4% |
| +91.3K |
| New Position |
| 5 | Compass Therapeutics Inc | 568.7K | $3.05M | 2.3% | +568.7K | New Position |
| 6 | Exelixis Inc | 68.6K | $3.01M | 2.3% | +68.6K | New Position |
| 7 | Axsome Therapeutics Inc | 13.0K | $2.37M | 1.8% | +13.0K | New Position |
| 8 | Tyra Biosciences Inc | 79.6K | $2.09M | 1.6% | +79.6K | New Position |
| 9 | Cogent Biosciences Inc | 54.0K | $1.92M | 1.5% | +54.0K | New Position |
| 10 | Tango Therapeutics Inc | 215.2K | $1.91M | 1.4% | +215.2K | New Position |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio